'Urol' diaporamas de présentation

Urol - PowerPoint PPT Presentation


Figure 1 Model of the maintenance of prostate epithelial parenchyma

Figure 1 Model of the maintenance of prostate epithelial parenchyma

Figure 1 Model of the maintenance of prostate epithelial parenchyma. Czyz˙, J. et al. (2012) The role of connexins in prostate cancer promotion and progression Nat. Rev. Urol. doi:10.1038/nrurol.2012.14.

By dyami
(154 views)

Figure 2 Gap - junction - dependent and gap - junction - independent functions of connexins

Figure 2 Gap - junction - dependent and gap - junction - independent functions of connexins

Figure 2 Gap - junction - dependent and gap - junction - independent functions of connexins. Czyz˙, J. et al. (2012) The role of connexins in prostate cancer promotion and progression Nat. Rev. Urol. doi:10.1038/nrurol.2012.14.

By ahava
(202 views)

Stewart, G. D. et al. (2011)

Stewart, G. D. et al. (2011)

Figure 1 Intratumoral heterogeneity of carbonic anhydrase IX (CAIX) expression (red signal) in renal cell carcinoma, by automated quantitative analysis. Stewart, G. D. et al. (2011) What can molecular pathology contribute to the management of renal cell carcinoma?

By malise
(101 views)

Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy

Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy

Figure 2 Current approach for identifying targets and the need to consider cellular heterogeneity in the normal and cancerous prostate. Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy Nat. Rev. Urol. doi:10.1038/nrurol.2012.157.

By galia
(91 views)

Figure 1 Epithelial hierarchy within prostate cancer

Figure 1 Epithelial hierarchy within prostate cancer

Figure 1 Epithelial hierarchy within prostate cancer. Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy Nat. Rev. Urol. doi:10.1038/nrurol.2012.157.

By rico
(81 views)

Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy

Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy

Table 1 Current and next-generation treatments for patients with castration-resistant prostate cancer*. Rane, J. K. et al . (2012) Advanced prostate cancer—a case for adjuvant differentiation therapy Nat. Rev. Urol. doi:10.1038/nrurol.2012.157.

By gerek
(125 views)

Figure 7 CDUS screen shots and spectral analysis of Sarteschi grade 4 reflux

Figure 7 CDUS screen shots and spectral analysis of Sarteschi grade 4 reflux

Figure 7 CDUS screen shots and spectral analysis of Sarteschi grade 4 reflux. Cimador, M. et al. (2012) The hemodynamic approach to evaluating adolescent varicocele Nat. Rev. Urol. doi:10.1038/nrurol.2012.41.

By kyoko
(131 views)

Figure 4 The putative FLCN pathway

Figure 4 The putative FLCN pathway

Figure 4 The putative FLCN pathway. Linehan, W. M. et al. (2010) The genetic basis of kidney cancer: a metabolic disease Nat. Rev. Urol. doi:10.1038/nrurol.2010.47.

By raanan
(111 views)

Table 2 Studies investigating the symptoms of GUTB*

Table 2 Studies investigating the symptoms of GUTB*

Table 2 Studies investigating the symptoms of GUTB*. Abbara, A. & Davidson, R. N. (2011) Etiology and management of genitourinary tuberculosis Nat. Rev. Urol. doi:10.1038/nrurol.2011.172.

By rusty
(80 views)

Table 1 LUTO subtypes and associated anomalies with total prevalence

Table 1 LUTO subtypes and associated anomalies with total prevalence

Table 1 LUTO subtypes and associated anomalies with total prevalence. Kilby, M. D. & Morris, R. K. (2014) Fetal therapy for the treatment of congenital bladder neck obstruction Nat. Rev. Urol. doi:10.1038/nrurol.2014.132.

By milly
(115 views)

Yuasa, T. & Urakami, S. (2014) Decreased incidence of skeletal‑related events in mRCC

Yuasa, T. & Urakami, S. (2014) Decreased incidence of skeletal‑related events in mRCC

Figure 1 Advances in the diagnosis and treatment of bone metastases secondary to renal cell carcinoma (RCC). Yuasa, T. & Urakami, S. (2014) Decreased incidence of skeletal‑related events in mRCC Nat. Rev. Urol. doi:10.1038/nrurol.2014.56.

By shaw
(69 views)

Table 2 Annual prostate cancer MRSI milestones on 1.5 T scanners, 2000–2010

Table 2 Annual prostate cancer MRSI milestones on 1.5 T scanners, 2000–2010

Table 2 Annual prostate cancer MRSI milestones on 1.5 T scanners, 2000–2010. DeFeo, E. M. et al. (2011) A decade in prostate cancer: from NMR to metabolomics Nat. Rev. Urol. doi:10.1038/nrurol.2011.53.

By bertha
(113 views)

Table 1 UTI in series of patients with nonrefluxing hydronephrosis or PNRM*

Table 1 UTI in series of patients with nonrefluxing hydronephrosis or PNRM*

Table 1 UTI in series of patients with nonrefluxing hydronephrosis or PNRM*. Castagnetti, M. et al. (2012) Antibiotic prophylaxis in antenatal nonrefluxing hydronephrosis, megaureter and ureterocele Nat. Rev. Urol. doi:10.1038/nrurol.2012.89.

By chibale
(135 views)

Trends in Regionalization of Inpatient Care for Urological Malignancies

Trends in Regionalization of Inpatient Care for Urological Malignancies

Trends in Regionalization of Inpatient Care for Urological Malignancies. Matthew R. Cooperberg Sanjukta Modak Badrinath R. Konety Department of Urology University of California, San Franicsco AHRQ Annual Conference Bethesda, MD September 10, 2008.

By melosa
(90 views)

Figure 2 PRLR signaling in prostate epithelium and current drug development strategies

Figure 2 PRLR signaling in prostate epithelium and current drug development strategies

Figure 2 PRLR signaling in prostate epithelium and current drug development strategies. Goffin, V. et al. (2011) Prolactin regulation of the prostate gland: a female player in a male game Nat. Rev. Urol. doi:10.1038/nrurol.2011.143.

By calder
(83 views)

Lymphadenectomy in the surgical treatment of prostate cancer - does it influence survival?

Lymphadenectomy in the surgical treatment of prostate cancer - does it influence survival?

Lymphadenectomy in the surgical treatment of prostate cancer - does it influence survival?. Oliver Hakenberg Urologische Klinik und Poliklinik Universitätsklinikum Rostock. Incidence and mortality of prostate cancer in Europe 1998. Davidson & Gabbay, WHO Report 2007. Pelvic lymphadenectomy.

By chynna
(198 views)

Table 2 Outcomes of RARC with ICUD

Table 2 Outcomes of RARC with ICUD

Table 2 Outcomes of RARC with ICUD. Azzouni, F. (2012) Current status of robot-assisted radical cystectomy for bladder cancer Nat. Rev. Urol. doi:10.1038/nrurol.2012.144.

By denali
(109 views)

Καρύδας Γιώργος, MD, PhD, FEBU Ουρολόγος

Καρύδας Γιώργος, MD, PhD, FEBU Ουρολόγος

Λαπαροσκοπική ριζική προστατεκτομή Νέα δεδομένα για το κλινικό όφελος και τη σχέση κόστους – αποτελεσματικότητας. Καρύδας Γιώργος, MD, PhD, FEBU Ουρολόγος. Κλινική Αγ. Λουκάς, Πανόραμα, Θεσσαλονίκη. Ιστορική αναδρομή.

By art
(175 views)

Figure 4 Prevalence of hypogonadism according to different definitions

Figure 4 Prevalence of hypogonadism according to different definitions

Figure 4 Prevalence of hypogonadism according to different definitions. Corona, C. & Maggi, M. (2009) The role of testosterone in erectile dysfunction Nat. Rev. Urol. doi:10.1038/nrurol.2009.235.

By zhen
(117 views)

nrurol.2009.235-pt3

nrurol.2009.235-pt3

Table 3 Trials of combined TRT and phosphodiesterase 5 inhibitors in men with erectile dysfunction. Corona, C. & Maggi, M. (2009) The role of testosterone in erectile dysfunction Nat. Rev. Urol. doi:10.1038/nrurol.2009.235.

By devi
(136 views)

View Urol PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Urol PowerPoint presentations. You can view or download Urol presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.